Chief Executive Officer
John Kupice is the CEO of H-Source and serves on its Board of Directors.
Before being named CEO in June 2014, John helped the founder Murray Walden with H-Source, LLC prepare a business plan, raise capital, and develop a new business model.
Prior to joining H-Source, John was vice president of Development for TruCare Solutions, Inc. John was responsible for the consolidation and analysis of patient outcome data for alternative treatment modalities. Previous to his work at TruCare, John was the chief executive officer for an entertainment technology company. He played a key role in the continued development of strategic reseller and supplier relationships, ensuring flexibility in response to an increasingly demanding marketplace, capital acquisition, and merger and acquisition of our main competitors. He also participated in various technology and venture capital initiatives in Minnesota, Florida, and Alabama.
John also spent 10 plus years with Ernst & Young, LLP, most recently as national director of the Lawson practice providing program management and implementation assistance for clients in multiple industries including healthcare in North America. Before that, John helped open consulting practices in strategic markets for Ernst & Young, LLP provided business migration services, continuous improvement methodologies, EXPRESS™ rapid process improvement, data warehousing, data visualization, and management reporting systems.
John earned an B.A. in accounting from the University of West Florida.
J. Murray Walden has been in the medical industry for over 20 years.
Prior to founding H-Source, Murray worked as a medical device sales representative and manager for multiple companies ranging from specialty distributors to Fortune 500 companies.
Murray has significant experience in medical device development, marketing, implementation into clinical use for most major surgery specialties in hospitals. He has coordinated vendor and hospital teams on product evaluations and conversions based on GPO (Group Purchasing Organization) and IDN (Integrated Delivery Network) contracts including major medical centers in the western U.S. and has worked closely with all levels of hospital supply chain processes.
Additionally, Murray has facilitated physician clinical education labs and a symposium for improving clinical outcomes and education for physicians. His unique industry background has provided significant value in crafting the H-Source platform. He continues to coordinate many of the daily operations at H-Source and focus on company initiatives and growth.
Murray attended Washington State University for two years and transferred to Iowa State University where he received a B.S degree and attended graduate school.
Chief Financial Officer
Ms. Lok is a Chartered Professional Accountant and a graduate of the Chartered Institute of Secretaries. She holds a Bachelor of Commerce degree in Accounting and Transportation Logistics from the University of British Columbia. Ms. Lok is currently a Senior Manager, Corporate Finance of Baron Global Financial Canada Ltd. Previously, she was a professional accountant with an international accounting firm where she gained valuable experience in audits for public multi-national clients.
Board of Directors
President Emeritus, American Hospital AssociationRead Bio >
Chief Investment Officer, AGFRead Bio >
VP of Business Development Affirm, Inc.Read Bio >
Chief Financial Officer, Confederation Minerals Ltd.Read Bio >
Some of the information or materials made available on this website may contain forward-looking statements. H-Source assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
2016Quarterly Financial – 9/30/2016 (PDF) ›MD&A – 9/30/2016 (PDF) ›Quarterly Financial – 06/30/2016 (PDF) ›MD&A – 06/30/2016 (PDF) › Quarterly Financial – 03/31/2016 (PDF) › MD&A – 03/31/2016 (PDF) ›
Press & Communication
01/19/2017READ RELEASE (PDF) >
12/6/2016READ RELEASE (PDF) >
11/17/2016READ RELEASE (PDF) >
We'd Love to Hear From You.
Questions for the Investor Relations department can be submitted below.